Fig. 5From: Integration of single-cell and bulk RNA sequencing to establish a prognostic signature based on tumor-associated macrophages in colorectal cancerCorrelation between tumor immune microenvironment, immunotherapy response and risk score. (A) The expression of immune checkpoint genes in patients in the two risk groups from TCGA-CRC. Spearman’s correlation analysis of the immune score (B), stromal score (C), EMT score (D), mRNAsi (E) and risk score. (F) A bar plot shows the proportion of CR/PR and SD/PD in patients in the high- and low-risk groups from GSE91061, GSE78220 (G), and GSE60331 cohort (H). * P < 0.05, ** P < 0.01, *** P < 0.001, **** P < 0.0001Back to article page